Evidence map›Paper›PMID 24688680›Full record

ReviewComputational and structural biotechnology journal2012

Engineering microbes for plant polyketide biosynthesis.

François-Xavier Lussier, David Colatriano, Zach Wiltshire, Jonathan E Page, Vincent J J Martin

Open access · goldAbstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Stable Platform for Mevalonate Bioproduction from COACS sustainable chemistry & engineering · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Enhancing glutaric acid production in Escherichia coli by uptake of malonic acid.Journal of industrial microbiology & biotechnology · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Heterologous production of curcuminoids.Microbiology and molecular biology reviews : MMBR · 2015
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

François-Xavier LussierDepartment of Biology, Centre for Structural and Functional Genomics, Concordia University, 7141 Sherbrooke Street West, Montréal, Québec, Canada, H4B 1R6.
David ColatrianoDepartment of Biology, Centre for Structural and Functional Genomics, Concordia University, 7141 Sherbrooke Street West, Montréal, Québec, Canada, H4B 1R6.
Zach WiltshireDepartment of Biology, Centre for Structural and Functional Genomics, Concordia University, 7141 Sherbrooke Street West, Montréal, Québec, Canada, H4B 1R6.
Jonathan E PageNational Research Council of Canada, 110 Gymnasium Place, Saskatoon, Saskatchewan, Canada, S7N 0W9.
Vincent J J MartinDepartment of Biology, Centre for Structural and Functional Genomics, Concordia University, 7141 Sherbrooke Street West, Montréal, Québec, Canada, H4B 1R6.
Concordia University · CASaskatchewan Research Council (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyketides are an important group of secondary metabolites, many of which have important industrial applications in the food and pharmaceutical industries. Polyketides are synthesized from one of three classes of enzymes differentiated by their biochemical features and product structure: type I, type II or type III polyketide synthases (PKSs). Plant type III PKS enzymes, which will be the main focus of this review, are relatively small homodimeric proteins that catalyze iterative decarboxylative condensations of malonyl units with a CoA-linked starter molecule. This review will describe the plant type III polyketide synthetic pathway, including the synthesis of chalcones, stilbenes and curcuminoids, as well as recent work on the synthesis of these polyketides in heterologous organisms. The limitations and bottlenecks of heterologous expression as well as attempts at creating diversity through the synthesis of novel "unnatural" polyketides using type III PKSs will also be discussed. Although synthetic production of plant polyketides is still in its infancy, their potential as useful bioactive compounds makes them an extremely interesting area of study.

Indexed as

metabolic engineeringmicrobesPlant polyketide

Identifiers

PMID24688680
PMCPMC3962132
OpenAlexW2048417461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.